<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-18452" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Physiology, Bone</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>El Sayed</surname>
            <given-names>Suzan A.</given-names>
          </name>
          <aff>Oakland Un William Beaumont Sch of Med</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Nezwek</surname>
            <given-names>Trevor A.</given-names>
          </name>
          <aff>Nova Southeastern University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Varacallo</surname>
            <given-names>Matthew</given-names>
          </name>
          <aff>Penn Highlands Healthcare System</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Suzan El Sayed declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Trevor Nezwek declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Matthew Varacallo declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>10</day>
          <month>9</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-18452.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The adult human skeleton is composed of 206 bones. At birth, there are approximately 270 bones, with the final adult count decreasing as a portion of these bones fuse&#x000a0;during phases of skeletal growth and maturation. Bone is a metabolically active connective tissue that provides structural support, facilitates movement, and protects vital organs; this tissue plays an important role in regulating mineral and acid-base balance homeostasis and also provides the environment for hematopoiesis (blood cell production) within the bone marrow. Bone is composed of an extracellular matrix and bone cells (osteocytes).<xref ref-type="bibr" rid="article-18452.r1">[1]</xref><xref ref-type="bibr" rid="article-18452.r2">[2]</xref></p>
      </sec>
      <sec id="article-18452.s2" sec-type="Function">
        <title>Function</title>
        <p>
<bold>Bone Cells&#x000a0;</bold>
</p>
        <p>Bone cells make up about 10%&#x000a0;of total bone volume. There are 4 types of cells:</p>
        <list list-type="order">
          <list-item>
            <p>Osteoprogenitor (stem) cells: Osteoprogenitor cells retain the ability to re-differentiate into osteoblasts. They reside in the bone canals, endosteum, periosteum, and marrow. They may regulate the influx and efflux of mineral ions into and out of the bone extracellular matrix. They also are responsible for the formation of bone remodeling compartments (BRC) with a specialized microenvironment.<xref ref-type="bibr" rid="article-18452.r3">[3]</xref></p>
          </list-item>
          <list-item>
            <p>Osteoblasts (bone-forming cells): They are tightly packed on the surface of the bone. They synthesize and secrete bone matrix (osteoid). They also regulate bone mineralization by secreting alkaline phosphatase (a marker for bone formation) and a set of proteins known as dentin matrix protein (DMP-1) and bone sialoprotein, which act as nucleators for mineralization. Osteocalcin and osteonectin are calcium and phosphate-binding proteins secreted by osteoblasts, which regulate the deposition of minerals by regulating the number of hydroxyapatite crystals. Osteoblasts ultimately have one of two fates: (1) remain quiescent osteoblasts lining cells or (2) become osteocytes. Osteoblasts regulate osteoclastogenesis (osteoclast formation) and osteocyte formation. Vitamin D and parathyroid hormone (PTH) stimulate osteoblasts to secrete macrophage cerebrospinal fluid (CSF) and express osteoprotegerin ligands, which are important for osteoclastogenesis (see<bold> Image.</bold> Osteoclastogenesis).<xref ref-type="bibr" rid="article-18452.r4">[4]</xref></p>
          </list-item>
          <list-item>
            <p>Osteocytes (mechanosensing cells): These account for 90% of all bone cells. They are derived from osteoblasts. They reside within the bone network&#x000a0;known as the lacuna canalicular system. They do not normally express alkaline phosphatase but do&#x000a0;express osteocalcin and other bone matrix proteins. They maintain a connection with each other and bone surfaces via their cytoplasmic processes. Osteocytes are linked metabolically and electrically through gap junctions. Their primary function is mechanosensation. Osteocytes detect mechanical loading through the physical deformation of bone matrix and fluid flow shear stress resulting from the flow of canalicular fluid through the lacuna canalicular network. Osteocytes act as orchestrators of bone remodeling and as a result, are&#x000a0;also considered endocrine cells. They secrete fibroblast growth factor-23 (FGF23) to regulate serum phosphate levels. FGF23 decreases renal and intestinal sodium and phosphate co-transporter expression and subsequently increases renal phosphate excretion by both kidneys.<xref ref-type="bibr" rid="article-18452.r5">[5]</xref></p>
          </list-item>
          <list-item>
            <p>Osteoclasts (bone-resorbing cells): These are multinucleated cells that originated from mononuclear monocyte-macrophage cells. Receptor activator of nuclear factor kappa beta (RANKL) and macrophage CSF are 2 cytokines that are&#x000a0;critical for osteoclast formation. They are important for osteoclast precursors to proliferate and differentiate into mature osteoclasts. Osteoprotegerin is a membrane-bound secreted protein that binds RANKL (see figure) to inhibit its action at the RANK receptor and subsequently inhibit osteoclastogenesis. Bone resorption depends on osteoclast secretion of hydrogen ions, tartrate-resistant acid phosphatase (TRAP), and cathepsin K enzymes. Hydrogen ions acidify the resorption compartment beneath osteoclasts to dissolve the mineral component of the bone matrix, whereas cathepsin K and TRAP digest the proteinaceous matrix, which is mostly composed of type I collagen. PTH stimulates osteoclast activity while calcitonin inhibits it.<xref ref-type="bibr" rid="article-18452.r6">[6]</xref><bold>&#x000a0;</bold></p>
          </list-item>
        </list>
        <p>
<bold>Bone Extracellular Matrix</bold>
</p>
        <p>The bone extracellular matrix makes up 90%&#x000a0;of the overall bone volume and consists of inorganic (mineral) and organic matrices.</p>
        <list list-type="bullet">
          <list-item>
            <p>Inorganic bone matrix accounts for 99% of the body's storage of calcium, 85% of the phosphorus, and 40% to 60% of the magnesium and sodium. It is mainly in the form of hydroxyapatite [Ca10(PO4)6(OH)2] to provide the bone its strength, stiffness, and resistance to compressive forces.</p>
          </list-item>
          <list-item>
            <p>Organic bone matrix is secreted by osteoblasts and is predominantly type I collagen; this also contains glycoproteins, growth factors, and proteoglycans. Growth factors (such as osteocalcin, osteonectin, and bone sialoprotein) play important roles in osteoid formation, mineralization, and bone remodeling. The organic matrix gives bone its form and provides resistance to tensile forces.<xref ref-type="bibr" rid="article-18452.r7">[7]</xref> &#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>Bone Remodeling</bold>
</p>
        <p>This&#x000a0;is a physiological process in which old or damaged bone is removed by osteoclasts and then replaced by new bone formed by osteoblasts. Bone formation and resorption are tightly coupled to ensure no net change in bone mass or quality after each remodeling. Bone remodeling requires the coordinated action of the four types of&#x000a0;bone cells.</p>
        <p>The process involves 4 major distinct but overlapping phases:</p>
        <list list-type="bullet">
          <list-item>
            <p>Phase 1: Initiation/activation of bone remodeling at a specific site. The osteoclast precursors are recruited to bone remodeling compartments (BRC).</p>
          </list-item>
          <list-item>
            <p>Phase 2: Bone resorption and concurrent recruitment of osteoprogenitors. Bone resorption represents the predominant event, but the recruitment of mesenchymal stem cells (MSCs) and/or osteoprogenitors into the BRC is also initiated.</p>
          </list-item>
          <list-item>
            <p>Phase 3: Osteoblast differentiation and function (osteoid synthesis). Excavated bone is replaced with osteoid produced by osteoblasts.</p>
          </list-item>
          <list-item>
            <p>Phase 4: Mineralization of osteoid and completion of bone remodeling. The osteoid is mineralized, and the bone remodeling cycle is concluded.<xref ref-type="bibr" rid="article-18452.r8">[8]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-18452.s3" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>
<bold>Osteoporosis</bold>
</p>
        <p>Osteoporosis is a common disorder of bone remodeling, which is characterized by low bone mass and structural deterioration of bone, causing increased fragility and vulnerability to fractures. There are 2 types of osteoporosis:</p>
        <p>
<bold>Primary Osteoporosis</bold>
</p>
        <p><bold>Type I </bold>(Postmenopausal Osteoporosis)</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Cause:</bold> a decline in estrogen levels associated with menopause</p>
          </list-item>
          <list-item>
            <p><bold>Pathophysiology:</bold> estrogen deficiency causes an increase in osteoclast activity by increasing RANKL and M-CSF expression and inhibiting osteoclast apoptosis by reducing FasL expression by preosteoclasts</p>
          </list-item>
        </list>
        <p><bold>Type II </bold>(Age-Related Osteoporosis or Senile Osteoporosis)</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Cause:</bold>&#x000a0;age-related and centered on osteoblasts (bone formation) in addition to bone resorption in postmenopausal women</p>
          </list-item>
          <list-item>
            <p><bold>Pathophysiology:</bold> decreased bone formation in men and women is caused by changes in reactive oxygen species (ROS), insulin-like growth factor 1 (IGF-1), and PTH levels associated with aging</p>
          </list-item>
        </list>
        <p>
<bold>Glucocorticoid-induced Osteoporosis (Secondary Osteoporosis)</bold>
<bold/>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Cause:</bold>&#x000a0;Glucocorticoids are immunomodulatory drugs that are used to treat a variety of autoimmune disorders and inflammatory conditions such as rheumatoid arthritis and multiple sclerosis. Bone loss and increased risk of fractures are among the common side effects of glucocorticoid treatment.</p>
          </list-item>
          <list-item>
            <p><bold>Pathophysiology:</bold>&#x000a0;Glucocorticoids inhibit the differentiation of osteoprogenitors into osteoblasts and promote their differentiation into adipocytes (fat cells). They also increase osteoblast apoptosis and impair their functions. Additionally, glucocorticoids target mature osteoclasts to prolong their life span which worsens the imbalance between bone formation and bone resorption in favor of bone resorption.<xref ref-type="bibr" rid="article-18452.r9">[9]</xref><xref ref-type="bibr" rid="article-18452.r10">[10]</xref><xref ref-type="bibr" rid="article-18452.r11">[11]</xref><xref ref-type="bibr" rid="article-18452.r12">[12]</xref><xref ref-type="bibr" rid="article-18452.r13">[13]</xref><xref ref-type="bibr" rid="article-18452.r14">[14]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-18452.s4">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=18452&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=18452">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/18452/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=18452">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-18452.s5">
        <fig id="article-18452.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Osteoclastogenesis. Bone-resorbing osteoclasts originate from hemopoietic cells of the monocyte&#x02013;macrophage lineage under the control of bone-forming osteoblasts. Illustration includes RANKL, the receptor activator of NF-&#x003ba;B ligand; M-CSF, macrophage colony-stimulating factor; and OPG, osteoprotegerin. Contributed by KE Doyle, MEd</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="osteoclastogenesisnoletters-2" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-18452.s6">
        <title>References</title>
        <ref id="article-18452.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clarke</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Normal bone anatomy and physiology.</article-title>
            <source>Clin J Am Soc Nephrol</source>
            <year>2008</year>
            <month>Nov</month>
            <volume>3 Suppl 3</volume>
            <issue>Suppl 3</issue>
            <fpage>S131</fpage>
            <page-range>S131-9</page-range>
            <pub-id pub-id-type="pmid">18988698</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18452.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dallas</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Prideaux</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bonewald</surname>
                <given-names>LF</given-names>
              </name>
            </person-group>
            <article-title>The osteocyte: an endocrine cell ... and more.</article-title>
            <source>Endocr Rev</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>34</volume>
            <issue>5</issue>
            <fpage>658</fpage>
            <page-range>658-90</page-range>
            <pub-id pub-id-type="pmid">23612223</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18452.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Corradetti</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Taraballi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Powell</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sung</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Minardi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ferrari</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Weiner</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Tasciotti</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Osteoprogenitor cells from bone marrow and cortical bone: understanding how the environment affects their fate.</article-title>
            <source>Stem Cells Dev</source>
            <year>2015</year>
            <month>May</month>
            <day>01</day>
            <volume>24</volume>
            <issue>9</issue>
            <fpage>1112</fpage>
            <page-range>1112-23</page-range>
            <pub-id pub-id-type="pmid">25517215</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18452.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Caetano-Lopes</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Canh&#x000e3;o</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fonseca</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Osteoblasts and bone formation.</article-title>
            <source>Acta Reumatol Port</source>
            <year>2007</year>
            <season>Apr-Jun</season>
            <volume>32</volume>
            <issue>2</issue>
            <fpage>103</fpage>
            <page-range>103-10</page-range>
            <pub-id pub-id-type="pmid">17572649</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18452.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aarden</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Burger</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Nijweide</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Function of osteocytes in bone.</article-title>
            <source>J Cell Biochem</source>
            <year>1994</year>
            <month>Jul</month>
            <volume>55</volume>
            <issue>3</issue>
            <fpage>287</fpage>
            <page-range>287-99</page-range>
            <pub-id pub-id-type="pmid">7962159</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18452.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boyce</surname>
                <given-names>BF</given-names>
              </name>
              <name>
                <surname>Yao</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Xing</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Osteoclasts have multiple roles in bone in addition to bone resorption.</article-title>
            <source>Crit Rev Eukaryot Gene Expr</source>
            <year>2009</year>
            <volume>19</volume>
            <issue>3</issue>
            <fpage>171</fpage>
            <page-range>171-80</page-range>
            <pub-id pub-id-type="pmid">19883363</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18452.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feng</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Chemical and Biochemical Basis of Cell-Bone Matrix Interaction in Health and Disease.</article-title>
            <source>Curr Chem Biol</source>
            <year>2009</year>
            <month>May</month>
            <day>01</day>
            <volume>3</volume>
            <issue>2</issue>
            <fpage>189</fpage>
            <page-range>189-196</page-range>
            <pub-id pub-id-type="pmid">20161446</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18452.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hadjidakis</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Androulakis</surname>
                <given-names>II</given-names>
              </name>
            </person-group>
            <article-title>Bone remodeling.</article-title>
            <source>Ann N Y Acad Sci</source>
            <year>2006</year>
            <month>Dec</month>
            <volume>1092</volume>
            <fpage>385</fpage>
            <page-range>385-96</page-range>
            <pub-id pub-id-type="pmid">17308163</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18452.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feng</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>McDonald</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Disorders of bone remodeling.</article-title>
            <source>Annu Rev Pathol</source>
            <year>2011</year>
            <volume>6</volume>
            <fpage>121</fpage>
            <page-range>121-45</page-range>
            <pub-id pub-id-type="pmid">20936937</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18452.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Henriksen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bollerslev</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Everts</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Karsdal</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Osteoclast activity and subtypes as a function of physiology and pathology--implications for future treatments of osteoporosis.</article-title>
            <source>Endocr Rev</source>
            <year>2011</year>
            <month>Feb</month>
            <volume>32</volume>
            <issue>1</issue>
            <fpage>31</fpage>
            <page-range>31-63</page-range>
            <pub-id pub-id-type="pmid">20851921</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18452.r11">
          <label>11</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Varacallo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Seaman</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Jandu</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Pizzutillo</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <chapter-title>Osteopenia</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>4</day>
            <pub-id pub-id-type="pmid">29763053</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18452.r12">
          <label>12</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Varacallo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Pizzutillo</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <chapter-title>Osteoporosis in Spinal Cord Injuries</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>28</day>
            <pub-id pub-id-type="pmid">30252365</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18452.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Varacallo</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Fox</surname>
                <given-names>EJ</given-names>
              </name>
            </person-group>
            <article-title>Osteoporosis and its complications.</article-title>
            <source>Med Clin North Am</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>98</volume>
            <issue>4</issue>
            <fpage>817</fpage>
            <page-range>817-31, xii-xiii</page-range>
            <pub-id pub-id-type="pmid">24994054</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18452.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Varacallo</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Fox</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Paul</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Hassenbein</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Warlow</surname>
                <given-names>PM</given-names>
              </name>
            </person-group>
            <article-title>Patients' response toward an automated orthopedic osteoporosis intervention program.</article-title>
            <source>Geriatr Orthop Surg Rehabil</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>4</volume>
            <issue>3</issue>
            <fpage>89</fpage>
            <page-range>89-98</page-range>
            <pub-id pub-id-type="pmid">24319621</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
